SCHEMBL278945

SCHEMBL278945

C=C(/N=C/c1cc(Br)ccc1I)O[Si](C)(C)C

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HPGD P15428 3/20 0.34
TSHR P16473 1/20 0.34
CASP1 P29466 3/20 0.33
CASP7 P55210 2/20 0.33
SMN1; SMN2 Q16637 2/20 0.33
ALDH1A1 P00352 2/20 0.33
GAA P10253 1/20 0.33
MAPT P10636 3/20 0.32
KDM4E B2RXH2 2/20 0.32
KMT2A Q03164 2/20 0.32
POLB P06746 1/20 0.32
AMY1A P0DUB6 1/20 0.32
LMNA P02545 2/20 0.32
L3MBTL1 Q9Y468 1/20 0.32
NPC1 O15118 1/20 0.30
CYP1A2 P05177 1/20 0.30
CYP3A4 P08684 1/20 0.30
CYP2D6 P10635 1/20 0.30
CYP2C9 P11712 1/20 0.30
CYP2C19 P33261 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL279006 0.83 HPGD (0.34) HPGDTSHRCASP1CASP7ALDH1A1
SCHEMBL275218 0.78 HPGD (0.41) HPGDTSHRSMN1; SMN2ALDH1A1GAA
SCHEMBL279190 0.76 CCR5 (0.43) HPGDTSHRSMN1; SMN2ALDH1A1GAA
SCHEMBL279339 0.75 LMNA (0.40) HPGDTSHRSMN1; SMN2ALDH1A1MAPT
SCHEMBL13929294 0.75 HPGD (0.44) HPGDTSHRALDH1A1MAPTKMT2A
SCHEMBL279202 0.75 HPGD (0.36) HPGDTSHRCASP1CASP7SMN1; SMN2
SCHEMBL278978 0.74 SYK (0.36) HPGDTSHRSMN1; SMN2ALDH1A1MAPT
SCHEMBL278990 0.74 LMNA (0.39) HPGDTSHRSMN1; SMN2ALDH1A1MAPT
SCHEMBL13928912 0.74 MAPT (0.39) SMN1; SMN2ALDH1A1GAAMAPTKDM4E
SCHEMBL13929174 0.73

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8134001-B2 Spiroindolinone derivatives HOFFMANN-LA ROCHE INC. (US) 2012-03-13 US disclosed
US-20090156610-A1 Spiroindolinone Derivatives DING QINGJIE 2009-06-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090156610-A1 Spiroindolinone Derivatives SDHA, AR, XPOT HPGD 482/4885TSHR 1261/4885CASP1 1016/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.